GenetureSeq Prep Kit-Hema 510 Panel Details

GenetureSeq Prep Kit-Hema 510 Panel

Hematologic Neoplasms are a group of malignant tumors originating from the hematopoietic or lymphatic system, involving the bone marrow, blood, and systemic lymphoid tissues, with high heterogeneity.

Its diagnosis and treatment require comprehensive analysis of morphology, immunology, genetics and molecular biology.

Next-generation sequencing (NGS), as a new molecular biology technology, has the advantages of high throughput, high sensitivity and low cost. It is an important means to explore the molecular pathogenesis of hematological malignancies and guide clinical diagnosis and treatment.

Geneture Hema 510 Panel kit is based on liquid phase hybridization capture and next generation sequencing technology, and can be used for research and analysis of hematological malignancies (AML, ALL, MPN, MDS). Hema 510 Panel covers all coding regions of genes involved in the Chinese expert consensus on the application of next generation sequencing technology in hematological malignancies, CDS region containing 500+ related genes, HLA-related genes, MSI, chemotherapy sites, and other related genes. A variety of mutation information (including point mutation, insertion/deletion, amplification, etc.) can be detected at the DNA level, which can assist the diagnosis, classification, prognosis determination, treatment guidance, minimal residual disease (MRD) detection, etc.

Model: 96T